All Episodes

From Finance to Pharmacovigilance: Lessons from Two Regulated Worlds

Transforming Benefit-Risk Assessment with AI

Inside PV Quality System: From Reactive QMS to AI-Supported Audits

From Freelancer to Award-Winning Founder: How to Build a Thriving Business in Pharma

MedDRA Matters: Behind the Scenes of International Standards

E2D(R1) Explained: Modern Safety Data Management Unpacked

Risk-Based Auditing in Pharmacovigilance: What Changes with EU Regulation 2025/1466?

Inside XEVMPD: Data, Safety and Strategy

The new CRO Business Playbook in the Age of AI

AI-Powered Literature Monitoring in Drug Safety

Clinical Trial Safety Reporting: What the 2025 UK Regulations Mean for You

EU Pharmacovigilance Regulation 2025/1466: Key Changes Explained

What Changed for UK Medicines After the Windsor Framework?

Data Protected: Inside EMA & OMS

The AI Safety Shift — EMA’s 2025–2028 Agenda

EMA Guidance on Anonymisation and Redaction of RMPs

EU Clinical Trials Regulation: The Full Implementation of the EU CTR

Navigating ICH E6(R3)

IRIS Transition simplified: Practical Guidance for MAHs

A New Era For Drug Safety

Roadmap to Regulatory Excellence in Pharmacovigilance

EMA AI Workshop: Safe & Responsible AI Use in PV

The AI Act: What It Means for Pharmacovigilance